Lloyd C. Trotman
Affiliations: | Molecular and Cellular Biology | Stony Brook University, Stony Brook, NY, United States |
Area:
Molecular Biology, Cell Biology, OncologyGoogle:
"Lloyd Trotman"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Amit M, Anastasaki C, Dantzer R, et al. (2024) Next Directions in the Neuroscience of Cancers Arising outside the CNS. Cancer Discovery. 14: 669-673 |
M Swamynathan M, Mathew G, Aziz A, et al. (2023) FABP5 Inhibition against -Mutant Therapy Resistant Prostate Cancer. Cancers. 16 |
Hillowe A, Gordon C, Wang L, et al. (2023) Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane-resistant prostate cancer cells. Plos One. 18: e0292483 |
Brina D, Ponzoni A, Troiani M, et al. (2023) The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells. Nature Cancer |
Aakula A, Isomursu A, Rupp C, et al. (2022) PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers. Molecular Oncology |
Taranda J, Mathew G, Watrud K, et al. (2021) Combined whole-organ imaging at single-cell resolution and immunohistochemical analysis of prostate cancer and its liver and brain metastases. Cell Reports. 37: 110027 |
Oni TE, Biffi G, Baker LA, et al. (2020) SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. The Journal of Experimental Medicine. 217 |
Monje M, Borniger JC, D'Silva NJ, et al. (2020) Roadmap for the Emerging Field of Cancer Neuroscience. Cell. 181: 219-222 |
Mathew G, Trotman LC. (2020) Competence against insufficiency: Why are men mostly safe from a rare and deadly prostate cancer? The Journal of Experimental Medicine. 217 |
Lee MF, Trotman LC. (2019) PTEN: Bridging Endocytosis and Signaling. Cold Spring Harbor Perspectives in Medicine |